Insider Trading History of Jensen Peder

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Jensen Peder since 2011. The trader's CIK number is 1518724. At the time of the last reporting, Jensen Peder was the Director of Five Prime Therapeutics, Inc.. (stock ticker symbol FPRX). Also see all insider trading activities at Five Prime Therapeutics, Inc..

Note that in the past Jensen Peder also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Biocryst Pharmaceuticals Inc (BCRX) by Jensen Peder

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 BCRX 40,000 $93,880 0 $0 0 $0
2011 BCRX 20,000 $63,100 0 $0 0 $0

Yearly summary of insider trading at Five Prime Therapeutics, Inc. (FPRX) by Jensen Peder

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 FPRX 0 $0 20,325 $1,053,241 20,325 $155,567


Insider trading activities at 2 companies by Jensen Peder:

1. Biocryst Pharmaceuticals Inc (BCRX)

2. Five Prime Therapeutics, Inc. (FPRX)

Table 1. Insider trading of Biocryst Pharmaceuticals Inc (BCRX) by Jensen Peder

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-12-14 BCRX Buy 20,000 1.51 30,200
2012-06-05 BCRX Buy 20,000 3.18 63,680
2011-11-18 BCRX Buy 10,000 2.75 27,500
2011-05-12 BCRX Buy 10,000 3.56 35,600

Table 2. Insider trading of Five Prime Therapeutics, Inc. (FPRX) by Jensen Peder

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-11-09 FPRX Sale 8,130 55.30 449,589
2016-11-09 FPRX Option Ex 8,130 6.40 52,032
2016-07-27 FPRX Option Ex 12,195 8.49 103,535
2016-07-27 FPRX Sale 12,195 49.50 603,652

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jensen Peder (Director of Five Prime Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.